Anti-ATXN1 Polyclonal Antibody, 50.0ul

£145.11
Delivery: 2 weeks
SKU
K008378P-50.0ul
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and AD

The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions.

  • Size: 50.0ul
  • Molecular Weight: 87kDa
  • Physical State: Liquid
  • Storage: Store at -20℃. Avoid freeze/thaw cycles.
  • Application: IHC;WB
  • Brand: Saint Michael
  • Catalogue No.: K008378P-50.0ul

For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.

Write Your Own Review
You're reviewing:Anti-ATXN1 Polyclonal Antibody, 50.0ul
© 2026 Excalibur Labware. All products are for laboratory research use only.